Primary amebic meningoencephalitis.
We report an 8 month-old infant with primary amebic meningoencephalitis (PAME) due to Naegleria fowleri. The child was treated with amphotericin B, chloramphenicol and rifampicin for 3 weeks. PAME is an almost universally fatal condition with very few survivors till date. Our patient was one of the rare survivors who recovered after treatment and was discharged without any residual neurological deficit.
Rai
Ruchi
R
Department of Pediatrics, MLN Medical College, University of Allahabad, Allahabad, UP, India. drruchi.rai@indiatimes.com
Singh
D K
DK
Srivastava
A K
AK
Bhargava
Anudita
A
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D008590:Meningoencephalitis / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology; D016848:Naegleria fowleri / Q000302:isolation & purification*; D011500:Protein Synthesis Inhibitors / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D011500:Protein Synthesis Inhibitors; D002701:Chloramphenicol; D000666:Amphotericin B; D012293:Rifampin